Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Natriuretic peptide-guided therapy: further research required for still-unresolved issues.

De Vecchis R, Esposito C, Cantatrione S.

Herz. 2013 Sep;38(6):618-28. doi: 10.1007/s00059-013-3772-8. Epub 2013 Apr 17. Review.

PMID:
23588602
2.

B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis.

De Vecchis R, Esposito C, Di Biase G, Ariano C, Giasi A, Cioppa C.

J Cardiovasc Med (Hagerstown). 2014 Feb;15(2):122-34. doi: 10.2459/JCM.0b013e328364bde1. Review.

PMID:
24522083
3.

The potential value of integrated natriuretic peptide and echo-guided heart failure management.

Scali MC, Simioniuc A, Dini FL, Marzilli M.

Cardiovasc Ultrasound. 2014 Jul 18;12:27. doi: 10.1186/1476-7120-12-27. Review.

4.

B-type natriuretic peptide in heart failure.

Moe GW.

Curr Opin Cardiol. 2006 May;21(3):208-14. Review.

PMID:
16601459
5.

Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure.

Pufulete M, Higgins JP, Rogers CA, Dreyer L, Hollingworth W, Dayer M, Nightingale A, McDonagh T, Reeves BC.

Syst Rev. 2014 May 2;3:41. doi: 10.1186/2046-4053-3-41. Review.

6.

[Will the therapy of chronic heart failure be guided by plasma levels of natriuretic peptides?].

Hradec J, Krupicka J, Janota T.

Cas Lek Cesk. 2009;148(8):383-8. Review. Czech.

PMID:
19899725
7.

Natriuretic peptide-guided therapy in chronic heart failure: a meta-analysis of 2,686 patients in 12 randomized trials.

Savarese G, Trimarco B, Dellegrottaglie S, Prastaro M, Gambardella F, Rengo G, Leosco D, Perrone-Filardi P.

PLoS One. 2013;8(3):e58287. doi: 10.1371/journal.pone.0058287. Epub 2013 Mar 5. Erratum in: PLoS One. 2014;9(4):e96706.

8.

The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure.

Maisel A, Xue Y, Greene SJ, Pang PS, Januzzi JL, Piña IL, DeFilippi C, Butler J.

J Card Fail. 2015 Mar;21(3):233-9. doi: 10.1016/j.cardfail.2014.11.009. Epub 2014 Nov 26. Review.

PMID:
25433362
9.

Biomarker guided therapy for heart failure: focus on natriuretic peptides.

Adams KF Jr, Felker GM, Fraij G, Patterson JH, O'Connor CM.

Heart Fail Rev. 2010 Jul;15(4):351-70. doi: 10.1007/s10741-009-9139-9. Review.

PMID:
19377882
10.

Natriuretic peptides in heart failure: where we are, where we are going.

Palazzuoli A, Antonelli G, Quatrini I, Nuti R.

Intern Emerg Med. 2011 Feb;6(1):63-8. doi: 10.1007/s11739-010-0438-x. Epub 2010 Sep 18. Review.

PMID:
20853071
11.

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis.

Troughton RW, Frampton CM, Brunner-La Rocca HP, Pfisterer M, Eurlings LW, Erntell H, Persson H, O'Connor CM, Moertl D, Karlström P, Dahlström U, Gaggin HK, Januzzi JL, Berger R, Richards AM, Pinto YM, Nicholls MG.

Eur Heart J. 2014 Jun 14;35(23):1559-67. doi: 10.1093/eurheartj/ehu090. Epub 2014 Mar 6. Review.

12.

Cost-effectiveness analysis of serial measurement of circulating natriuretic peptide concentration in chronic heart failure.

Laramée P, Wonderling D, Swain S, Al-Mohammad A, Mant J.

Heart. 2013 Feb;99(4):267-71. doi: 10.1136/heartjnl-2012-302692. Epub 2012 Dec 12.

PMID:
23236028
13.

BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.

Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP; TIME-CHF Investigators.

JAMA. 2009 Jan 28;301(4):383-92. doi: 10.1001/jama.2009.2.

PMID:
19176440
14.

Natriuretic peptides as biomarkers in heart failure.

Januzzi JL Jr.

J Investig Med. 2013 Aug;61(6):950-5. doi: 10.2310/JIM.0b013e3182946b69. Review.

15.

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials.

Brunner-La Rocca HP, Eurlings L, Richards AM, Januzzi JL, Pfisterer ME, Dahlström U, Pinto YM, Karlström P, Erntell H, Berger R, Persson H, O'Connor CM, Moertl D, Gaggin HK, Frampton CM, Nicholls MG, Troughton RW.

Eur J Heart Fail. 2015 Dec;17(12):1252-61. doi: 10.1002/ejhf.401. Epub 2015 Sep 30.

16.

Diagnostic Accuracy of Natriuretic Peptides for Heart Failure in Patients with Pleural Effusion: A Systematic Review and Updated Meta-Analysis.

Han ZJ, Wu XD, Cheng JJ, Zhao SD, Gao MZ, Huang HY, Gu B, Ma P, Chen Y, Wang JH, Yang CJ, Yan ZH.

PLoS One. 2015 Aug 5;10(8):e0134376. doi: 10.1371/journal.pone.0134376. eCollection 2015. Review.

17.

[Natriuretic peptides--new diagnostic markers in heart disease].

Angermann CE, Ertl G.

Herz. 2004 Sep;29(6):609-17. Review. German.

PMID:
15912436
18.

Natriuretic Peptides and the Management of Heart Failure.

Kern T, Kedan I, Kimchi A.

Rev Cardiovasc Med. 2015;16(2):95-104. Review.

PMID:
26198556
19.

The Current and Potential Clinical Relevance of Heart Failure Biomarkers.

Gandhi PU, Testani JM, Ahmad T.

Curr Heart Fail Rep. 2015 Oct;12(5):318-27. doi: 10.1007/s11897-015-0268-2. Review.

PMID:
26280466
20.

Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.

Felker GM, Hasselblad V, Hernandez AF, O'Connor CM.

Am Heart J. 2009 Sep;158(3):422-30. doi: 10.1016/j.ahj.2009.06.018. Epub 2009 Jul 9.

PMID:
19699866

Supplemental Content

Support Center